Cargando…

Selective inhibition of nuclear export: a promising approach in the shifting treatment paradigms for hematological neoplasms

Novel targeted therapeutics alone or in rational combinations are likely to dominate the future management of various hematological neoplasms. However, the challenges currently faced are the molecular heterogeneity in driver lesions and genetic plasticity leading to multiple resistance pathways. Thu...

Descripción completa

Detalles Bibliográficos
Autores principales: Balasubramanian, Suresh Kumar, Azmi, Asfar S., Maciejewski, Jaroslaw
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8885406/
https://www.ncbi.nlm.nih.gov/pubmed/35091658
http://dx.doi.org/10.1038/s41375-021-01483-z